The Dual Function of the Fungal Toxin Candidalysin duringCandida albicans-Macrophage Interaction and Virulence

被引:35
作者
Koenig, Annika [1 ]
Hube, Bernhard [1 ,2 ,3 ]
Kasper, Lydia [1 ]
机构
[1] Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoell Inst, Dept Microbial Pathogen Mech, D-07745 Jena, Germany
[2] Univ Hosp Jena, Ctr Sepsis Control & Care, D-07747 Jena, Germany
[3] Friedrich Schiller Univ, Inst Microbiol, D-07743 Jena, Germany
基金
欧盟地平线“2020”; 英国惠康基金;
关键词
candidalysin; cytolytic toxin; dual function; inflammasome activation; BLOOD-STREAM INFECTIONS; BACTERIAL TOXINS; NLRP3; INFLAMMASOME; TRANSCRIPTIONAL RESPONSE; PROTEOLYTIC ACTIVATION; SUPEROXIDE DISMUTASES; HOST-DEFENSE; PATHOGEN; ESCAPE; RECOGNITION;
D O I
10.3390/toxins12080469
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The dimorphic fungusCandida albicansis both a harmless commensal organism on mucosal surfaces and an opportunistic pathogen. Under certain predisposing conditions, the fungus can overgrow the mucosal microbiome and cause both superficial and life-threatening systemic infections after gaining access to the bloodstream. As the first line of defense of the innate immune response, infectingC. albicanscells face macrophages, which mediate the clearance of invading fungi by intracellular killing. However, the fungus has evolved sophisticated strategies to counteract macrophage antimicrobial activities and thus evade immune surveillance. The cytolytic peptide toxin, candidalysin, contributes to this fungal defense machinery by damaging immune cell membranes, providing an escape route from the hostile phagosome environment. Nevertheless, candidalysin also induces NLRP3 inflammasome activation, leading to an increased host-protective pro-inflammatory response in mononuclear phagocytes. Therefore, candidalysin facilitates immune evasion by acting as a classical virulence factor but also contributes to an antifungal immune response, serving as an avirulence factor. In this review, we discuss the role of candidalysin duringC. albicansinfections, focusing on its implications duringC. albicans-macrophage interactions.
引用
收藏
页数:14
相关论文
共 115 条
[71]   Revisiting the source of candidemia: Skin or gut? [J].
Nucci, M ;
Anaissie, E .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (12) :1959-1967
[72]   High-Throughput Screening Identifies Genes Required for Candida albicans Induction of Macrophage Pyroptosis [J].
O'Meara, Teresa R. ;
Duah, Kwamaa ;
Guo, Cynthia X. ;
Maxson, Michelle E. ;
Gaudet, Ryan G. ;
Koselny, Kristy ;
Wellington, Melanie ;
Powers, Michael E. ;
MacAlpine, Jessie ;
O'Meara, Matthew J. ;
Veri, Amanda O. ;
Grinstein, Sergio ;
Noble, Suzanne M. ;
Krysan, Damian ;
Gray-Owen, Scott D. ;
Cowen, Leah E. .
MBIO, 2018, 9 (04)
[73]   Global analysis of fungal morphology exposes mechanisms of host cell escape [J].
O'Meara, Teresa R. ;
Veri, Amanda O. ;
Ketela, Troy ;
Jiang, Bo ;
Roemer, Terry ;
Cowen, Leah E. .
NATURE COMMUNICATIONS, 2015, 6
[74]   Invasive candidiasis [J].
Pappas, Peter C. ;
Lionakis, Michail S. ;
Arendrup, Maiken Cavling ;
Ostrosky-Zeichner, Luis ;
Kullberg, Bart Jan .
NATURE REVIEWS DISEASE PRIMERS, 2018, 4
[75]   New Insights in Candida albicans Innate Immunity at the Mucosa: Toxins, Epithelium, Metabolism, and Beyond [J].
Pellon, Aize ;
Nasab, Shervin Dokht Sadeghi ;
Moyes, David L. .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
[76]   Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016 [J].
Pfaller, Michael A. ;
Diekema, Daniel J. ;
Turnidge, John D. ;
Castanheira, Mariana ;
Jones, Ronald N. .
OPEN FORUM INFECTIOUS DISEASES, 2019, 6 :S79-S94
[77]   Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome [J].
Pietrella, Donatella ;
Pandey, Neelam ;
Gabrielli, Elena ;
Pericolini, Eva ;
Perito, Stefano ;
Kasper, Lydia ;
Bistoni, Francesco ;
Cassone, Antonio ;
Hube, Bernhard ;
Vecchiarelli, Anna .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (03) :679-692
[78]   Caspase-1-Independent Interleukin-1β Is Required for Clearance of Bordetella pertussis Infections and Whole-Cell Vaccine-Mediated Immunity [J].
Place, David E. ;
Muse, Sarah J. ;
Kirimanjeswara, Girish S. ;
Harvill, Eric T. .
PLOS ONE, 2014, 9 (09)
[79]  
QIAN QF, 1994, J IMMUNOL, V152, P5000
[80]  
Richardson JP, 2018, MBIO, V9, DOI [10.1128/mBio.02178-17, 10.1128/mbio.02178-17]